Background 18
Alopecia areata (AA) is a complex disease defined by focal or universal hair loss, most commonly 19 occurring on the scalp [1] . Although benign, AA can seriously impair quality of life, such as negative 20 effects on self-perception and self-esteem[2], and even attempted suicide in rare cases [3] . The 21 prevalence of AA is approximately 0.1% to 0.2% in the United States, with a lifetime risk of 1.7% [4] , 22
while a twin study suggested a 55% concordance rate in identical twins with a significant occurrence 23 of AA in families [5] . In addition, the prevalence rate of AA in families has been shown to be higher 24 than that in the general public, though the rate varied in each study and population examined [6] [7] [8] [9] [10] . 25 AA is driven by cytotoxic T lymphocytes and was found to be reversed by Janus kinase (JAK) 26 inhibition in model mice by clinical treatment [11] , demonstrating that the immunological pathway is 27 a factor in this multifactorial disease. Previous genome-wide association study results have implicated 1 a number of immune and non-immune loci in the aetiology of AA [12] [13] [14] , though none has yet been 2 demonstrated to be causative for the disease. Thus, no variants among those have provided 3 experimental evidence for biological functions between alleles and AA pathogenesis. Alleles of the 4 human leukocyte antigen (HLA) genes within the major histocompatibility complex (MHC) region on 5 chromosome 6p21.3 have thus far shown the strongest associations with AA among the human 6 genome [12] [13] [14] in observations of different ethnic groups. However, the strongest associations with 7 AA have not been supported by functional evidence. 8
The genetic architecture of the MHC region shows that multiple haplotypes with the highest 9 degree of diversity are often maintained in a population by balancing selection, and that positive 10 selection can occasionally generate long-range haplotypes [15, 16] . The strong linkage disequilibrium 11 (LD) observed in such haplotypes can mask the ability to discriminate between a bona fide variant 12 associated with disease and a variant influenced by LD. This limitation can be addressed by analysis 13 of microsatellites that have higher mutation rates than SNPs, thus leading to breakup of apparently 14 invariant SNP haplotypes into lower frequency haplotypes for functional analysis [17] . Analysis of 15 multi-allelic microsatellites may therefore be an effective strategy for identifying rare disease-16 associated haplotypes in the MHC. 17
With this background in mind, we implemented a 4-step study design. First, we performed 18 association analysis using microsatellites for the entire MHC region with AA patients and healthy 19 controls to identify risk haplotypes associated with AA. Second, we sequenced representative risk and 20 control haplotypes to identify variants that were present only in identical risk haplotypes based on all 21 of the variants detected. Third, we performed whole exome sequencing of the variant-associated 22 candidate gene, haplotype estimation, and extended haplotype homozygosity (EHH) analysis in all 23 8 higher in those mice as compared to C3H/HeJ mice, which show spontaneously development of AA 1 with age. [24] Over time, the initial area of hair loss expanded in the majority of the AA mice ( Fig. 4a) , 2 though constant and recovered hair loss was observed in some of those mice (Additional file1: Figure  3 S7 and S8). The male to female ratio of alopecic AA mice was nearly equal, and their surface displayed 4 black spots, while the hairs appeared to be broken and tapering (Fig. 4b) , similar to the conditions 5 seen in humans with AA and specific for AA-associated hair loss [25] . Thus, an altered hair shaft 6 structure may be a feature concordant between human AA[26] and the present engineered AA mice. 7
All of the AA mice showed retained hair follicles in the area of hair loss and no signs of lymphocyte 8 infiltration were seen in microscopic observations ( Fig. 4c) , implying involvement of a non-immune 9 mechanism. 10 11
Microarray analysis of alopecic mice skin biopsies 12
To investigate the presence of a possible biological function underlying the observed hair loss 13 in the AA mice, we performed gene expression microarray analysis of dorsal and ventral skin biopsies 14 (Additional file1: Figure S9 and S10), which resulted in identification of 265 probes (246 genes) 15 with 2-fold or greater up-or down-regulation as compared to wild-type mice. The full list of genes is 16
shown Table S11 . Clustering analysis of these probes uncovered a strongly up-regulated gene cluster 17 in the AA mice ( Fig. 5a ), including hair-related genes ( Fig. 5b) . Nearly all of those up-regulated with 18 a greater than 25-fold change value were keratin [27] (n=12) and KRTAP (n=31) genes (Additional 19 file1: Table S9 ). Hair keratins and KRTAPs are the major structural components of the hair shaft, and 20 specifically expressed in the medulla, cortex, and cuticle layers of the shaft[28], and interaction 21 between hair keratins and KRTAPs suggest their contribution to its rigidity [29] . 22
Other up-regulated genes included peptidyl arginine deaminase type III (Padi3), S100 calcium 23 binding protein A3 (S100A3), trichohyalin (Tchh) [30] , and homeobox C13 (Hoxc13)[31] (Additional 24 file1: Table S9 ). In cuticular cells, S100A3 is a substrate of PADI3, while in inner root sheath (IRS) 25 cells of hair follicles it is a substrate of TCHH [30] . Ca2 + -dependent modifications of S100A3 and 26 TCHH by PADI3 play important roles in shaping and mechanically strengthening hair with hair 27 9 keratin[30, 32]. Hoxc13 is unique among the Hox genes, as it is expressed in the outer root sheath 1 (ORS), matrix, medulla, and IRS of hair follicles in a hair cycle-dependent manner, and it has a role 2 in hair shaft differentiation [31] . Thus, the majority of genes shown to be strongly up-regulated in AA 3 mice are involved in the hair shaft and its formation. 4
Hairless model mice, nude mice lacking forkhead box N1 (Foxn1), have a pleiotropic mutation 5 that leads to 2 independent phenotypic effects, which are disturbed development of hair follicles and 6 dysgenesis of the thymus [33] . The Foxn1 expression has been shown to be regulated by Hoxc13 in 7 hair follicles [34] , and both Hoxc13-null and Hoxc13-overexpressing transgenic mice were found to be 8 an alopecic phenotype [34] . These three alopecic mice lines display defective hair shafts or aberrant 9 hair cuticles [33, 35, 36] . In the present microarray analysis, Foxn1 expression in alopecic skin of AA 10 mice was also upregulated by 6.5-fold as compared to the wild-type mice, though this gene was ruled 11 out by the filtering criteria employed (Additional file1: Figure S11) . A comparison between gene 12 profiling results of Hoxc13-null [34] and AA mice indicated that the regulated genes were quite similar 13 between them ( Fig. 6 and Additional file1: Table S10 ). Thus, among 113 down-regulated genes with 14 a gene symbol in Hoxc13-null mice[34], 89 were upregulated in the AA mice (Additional file1: Table  15 S10), the majority of which were hair keratins or KRTAPs. Moreover, we observed a significant 16 inverse correlation of fold change values for these genes between these mouse lines ( Fig. 6) , despite 17 differences in strain and mutant genes. Therefore, Cchcr1 may be involved in the hair shaft 18 differentiation regulatory network controlled by Hoxc13, Foxn1, keratins, and KRTAPs, though the 19 regulation was in opposite directions. 20 Enrichment analysis of these 246 genes using the Database for Annotation, Visualization and 21
Integrated Discovery (DAVID) tool[37] showed Gene Ontology[38] (GO) terms relating to only 22 keratin and the intermediate filament, but not to any immunological pathways (Additional file1: Table  23 S11). 24
To confirm the microarray results, we performed quantitative PCR (qPCR) analysis of 7 of the 25 up-regulated genes and Cchcr1 using a comparative C T method [39] . Those results confirmed 26 significant differences between dorsal skin biopsies from areas of hair loss in the AA and wild-type 27 mice ( Fig. 7a and Additional file1: Figure S12 ). All AA mice showed highly concordant rank orders 1 of expression levels of the examined genes ( Fig. 7b and Additional file1: Figure S13 ), implicating 2 involvement of the regulatory network in hair shaft differentiation [34] . Finally, we evaluated the localization of CCHCR1 using immunostaining and electron 6 microscopy to delineate potential mechanisms underlying the observed hair loss in our mouse model. 7
Immunostaining revealed CCHCR1 to be located in the mid-to-upper hair shaft but not in the cell and 8 hair shaft within hair bulb ( Fig. 8a-i ), suggesting that CCHCR1 is a structural component, similar to 9 keratin, of the hair shaft. CCHCR1 was co-localized with the hair cortex and also found to be localized 10 in the hair medulla ( Fig. 8b, e and h) . Expression of this protein in the skin of AA mice was stronger 11 as compared to that of the wild type ( Fig. 8a-i) , supporting our findings of expression analysis using 12 RNAs ( Fig. 5a, b) . Hair keratins are known to be organized in bundles with structures dominated by 13 alfa-helical coiled-coils [40] . Using low-resolution immunostaining, we were not able to identify any 14 difference between the AA and wild-type mice. However, high-resolution scanning electron 15 microscopy (SEM) results demonstrated hair abnormalities, including turbulence in cuticle formation 16 and flattened shafts in alopecic AA mice ( Fig. 8p-x) . Alopecic AA mice displayed aberrant hair not 17 only in areas of hair loss ( Fig. 8x-t) , but also in normal areas ( Fig. 5s-u) . Moreover, AA mice that did 18 not yet show hair loss also displayed aberrant hair ( Fig. 8p-r Our finding that CCHCR is an AA-associated locus in the HLA class I region differs from that 24 of a previous genome-wide association study, which suggested that HLA-DR in the HLA class II region 25 is a key driver of AA aetiology [13] . One possible explanation for this seeming contradiction is that 26 our study may not have been sufficiently powered to detect the weak association with AA within the 27 HLA-class II region, though the microsatellites utilized covered the entire class II region as well ( Fig.  1   1a) . On the other hand, consistent with our finding, studies performed in Chinese using HLA genes as 2 markers suggested that the locus associated with AA maps to the class I rather than the class II 3 region[42-44]. Moreover, variant rs142986308 is very rare in Caucasians (Additional file1: Table S8 ) 4
and has undergone positive selection ( Fig. 1c) , at least in Japanese, suggesting population-specific 5 differences regarding AA risk haplotypes. This is the first study to show that an HLA class I allele, 6 rs142986308, can be functionally linked to the AA phenotype, which has not been demonstrated for 7 any other variant, including HLA-DR. 8
Previous studies have provided evidence of a relationship between CCHCR1 and hair keratin-9 related genes. For example, a risk haplotype (CCHCR1*WWCC) was previously implicated to be 10 involved in psoriasis in Europeans [21, 45] . Transgenic mice with the risk haplotype appeared normal, 11
though it was shown that overexpression of CCHCR1 affected keratinocyte proliferation [46] , and 12 hyperproliferation of keratinocytes is a hallmark for psoriasis. However, keratin-related genes showed 13 altered expression in mice at risk and most of the genes with significantly lower expression were those 14 encoding hair keratins or KRTAPs [47] . These observations suggested that expression of these genes 15 is dependent on the CCHCR1 haplotype. 16
AA shows clinical heterogeneity[48], thus findings from the lymphocyte infiltration model as 17
well as the AA mice are not able to fully explain the pathogenesis. Those obtained with AA mice may 18 be more suitable to explain aberrant hair shaft results, such as black dots (cadaverized hairs), tapering 19 hairs, and broken hairs, which are specific AA-associated hair loss conditions [25] . Therefore, 20 investigation of the relationship between autoimmunity response and aberrant keratinization in hair 21 follicles may lead to a better understanding of AA pathogenesis. Conversely, each model may have an 22 independent pathway, leading to AA heterogeneity. 23
The current study has several limitations thus further studies are needed. First, more detailed 24 investigation of immunological function in AA mice must be performed, because the present study did 25 not completely exclude immunological aspects. Second, additional examination of factors that 26 eventually lead to hair loss is needed, though all of the AA mice displayed abnormal hair shafts. In 27 addition, investigation of how the mutation alters the function of the CCHCR1 protein is necessary. 1
Finally, it is important to investigate hairs and hair follicles obtained from patients with and without 2 the risk allele in order to fully understand the functions of CCHCR1 in human hair. 3
In summary, we identified a novel AA susceptibility variant (T allele of rs142986308, 4 p.Arg587Trp) in the human MHC class I region and established an alopecic mouse model. Findings 5 of functional analyses indicate that CCHCR1 is a novel component in hair shafts and its variation 6 alters the coiled-coil formation of CCHCR1, resulting in abnormalities of hair shafts and cuticles, 7 along with up-regulation of hair keratin, KRTAPs, and other relevant genes, ultimately leading to AA 8 pathogenesis, shown by fragile and impaired hair as well as hair loss. In addition, our findings suggest 9
an alternative pathway for that pathogenesis based on aberrant keratinization. Together with the 10 present engineered mice, our results provide a valuable resource for continued research of AA 11 pathogenesis and development of potential future treatments. 12 13
Conclusions 14
This study genetically identifies an AA susceptibility variant by association and sequencing analysis 15 within the MHC region, and functionally confirms that the variant involves hair abnormalities using 16 engineered mice by CRISPR/Cas9 for allele-specific genome editing. 
HLA-C locus genotyping 18
A LABType ® SSO typing test produced by ONE LAMBDA (Inc., Canoga Park, CA) was 19 utilized. This product is based on the reverse SSO method for use with a suspension array platform 20 with microspheres as a solid support to immobilize oligonucleotide probes. Target DNA is amplified 21 by PCR, then hybridized to the bead probe array, followed by flow analysis using a LABScan™ 100 22 flow analyzer (ONE LAMBDA). HLA-C locus genotype data from 156 AA patients and 560 controls 23 obtained in our previous study [18] were used and we also genotyped an additional 15 AA cases as part 24 of the present study. 25 26
Genomic library construction and sequencing 27
For HLA region capture and sequencing, genomic DNA (2 μg) was sheared to approximately 1 500 bp in size using a Covaris Acoustic Adaptor. Genomic libraries were prepared using a TruSeq 2 DNA Sample Preparation kit. v.2 (Illumina, San Diego, CA, USA) following the manufacturer's 3 instructions, which involved size selection of DNA fragments of 550-650 bp in length on 2% agarose 4 gels. HLA region enrichment was performed with an adaptor-ligated DNA sample library using the 5
SeqCap EZ Choice Library Human MHC Design system (Roche NimbleGen, Madison, WI, USA) 6
[50], according to the manufacturer's instructions. To quantify and verify the genomic libraries, all 7
samples were analyzed with a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA) using 8 an Agilent DNA 1000 kit prior to sequencing (Additional file1: Figure S16 ). Sequence analysis was 9 performed with the Illumina Genome Analyzer IIx platform, using a paired-end sequencing protocol 10 (2×100 bp). We sequenced 5 risk and 7 non-risk haplotypes to a mean depth of 249 reads (Additional 11 file1: Table S3 ), covering 95.2% (mean) of the 4.97-Mb MHC region (chr6:28477797-33451433, 12 hg19) with at least 10 reads (Additional file1: Table S3 ). realignment, map quality score recalibration, and variant detection [53] . SNVs and indels were then 23 annotated for functional consequences at the gene and protein sequence levels using ANNOVAR [54] . 24
Finally, we manually checked the raw sequencing data using Tablet, a sequence assembly visualization 25 tool[55] (Additional file1: Figure S2) . 
Statistical analysis 18
Logistic regression models were used to assess the genetic effects of multi-allelic loci, SNVs, 19
and AA risk haplotypes. Comparisons of genotype and haplotype frequency differences were done by 20 regression analysis for log-additive models [56] . Unadjusted odds ratio (OR) and 95% confidence 21 intervals (95% CI) were calculated. Analysis was carried out using the SNPassoc R library [56] . For 22 these association analyses, we used Bonferroni-corrected values to account for the problem of multiple 23 testing to a threshold P value of 1.98x10 -04 , after accounting for multiple testing of 252 alleles in 23 24 multi-allelic loci for the first microsatellite analysis. An exact P-value test of Hardy-Weinberg 25 proportion and evaluation of LD (linkage disequilibrium) for multi-allelic loci were simulated by the 26 
Prediction of coiled-coil domain and structural analyses 17
Multiple sequence alignment was performed with CLUSTALW (http://www.genome.jp/). To 18 predict coiled-coil domains within the amino acid sequence of CCHCR1, we used 2 different programs, 19
COILS[63]
(http://embnet.vital-it.ch/software/COILS_form.html) and Paircoil2[64, 65] 20 (http://groups.csail.mit.edu/cb/paircoil2/), with the following recommended default settings: COILS 21 v2.2 with a window size of 28 and the MTIDK table, and Paircoil2 with a window size of 28 and P-22 score cutoff of 0.025. 23
The amino acid sequence of CCHCR1 (GenBank accession: NP_061925.2) was obtained from 24 the NCBI GenBank database (https://www.ncbi.nlm.nih.gov) and used as a target for homology 25 modeling. After PSI-BLAST searches[66] of protein databank (PDB) sequence entries 26 (http://www.rcsb.org/pdb/) using the CCHCR1 sequence, the crystal structure of the human lamin-B1 27 coil 2 segment (PDB ID: 3TYY[23]) was selected as the best template for homology modeling. The 1 partial 3TYY structure was optimized and used as a template to generate 50 homology models using 2 the Build Homology Models protocol. Probability Density Function total energy and Discrete 3
Optimized Potential Energy scores were used to select the best model. Protein stability for mutants 4 was calculated using the Calculate Mutation Energy (Stability) protocol. All molecular modeling and 5 simulation were performed with Discovery Studio, v. 4.1, from BIOVIA (Accelrys Inc. San Diego, 6 USA) with the default parameter setting. 7 8
Genome editing by CRISPR/Cas9 in mouse embryos 9
To generate mice carrying the p.Arg587Trp disease-associated missense variant, we edited the 10 Cchcr1 codon sequence of amino acid 591 in mice using the following protocol (Fig.3 ). Cas9 mRNA 11 was prepared using a pBGK plasmid, as previously described. 
RNA isolation 1
Total RNA was isolated from sections of mouse skin using ISOGEN (Nippon Gene, Tokyo, 2 Japan), according to the manufacturer's protocol, and treated twice with TURBO DNase (Ambion) to 3 eliminate contaminating DNA. RNA was quantified using a NanoDrop 2000 (Thermo Fisher 4 Scientific) and the quality of the extracted RNA was evaluated with a Bioanalyzer 2100 (Agilent 5 Technologies). 6 7
Microarray analysis 8
Fluorescent cRNA synthesis derived from skin RNAs was performed using a Low RNA Input 9
Linear Amplification kit (Agilent Technology) and subjected to DNA microarray analysis with single-10 color microarray-based gene-expression analysis (SurePrint G3 Mouse GE, v. 2.0, 8x60 K, Agilent 11 Technology). All procedures were performed according to the manufacturer's instructions. Data from 12 samples that passed the QC parameters were subjected to 75th percentile normalization and analyzed 13
using Genespring GX (version 12, Agilent Technologies). Gene ontology enrichment analysis was 14 performed with DAVID 6.8 (https://david.ncifcrf.gov/) using 3 functional database (Cellular 15 Component, Biological Process and Molecular Function). Significance values were calculated 16 between the AA and wild-type mice using Spearman's rank correlation coefficient (paired, two-tailed). 17
18
Quantitative PCR 19 cDNAs were synthesized using 1 μg of total RNA in a 20-μl total volume using SuperScript ® 20 VILO™ MasterMix (Thermo Fisher Scientific) and random hexamers. Quantitative PCR was 21 performed using a StepOnePlus™ Real-Time PCR System, TaqMan ® Universal Master Mix, and 22
TaqMan gene expression assay (Thermo Fisher Scientific), according to the manufacturer's protocol. 23
The primer-probe sets were as follows: Mm00652053_g1 (Krt34), Mm02345064_m1 (Krt73), 24
Mm01214103_g1 (S100a3), Mm00461542_m1 (Cchcr1), and Mm99999915_g1 (Gapdh) (Thermo 26
Fisher Scientific). All PCR reactions were performed in triplicate. Relative quantification of gene 27 20 expression was performed using the 2 −ΔΔCt method [39] . Fold change values were calculated using 1
Gapdh as the internal control and a dorsal skin sample from a wild-type mouse was used as a calibrator. 2
Significance values were calculated between the AA and wild-type mice using Student's t-test 3 (unpaired, two-tailed). Anti-CCHCR1 (rabbit polyclonal) and anti-hair cortex cytokeratin antibodies (mouse 7 monoclonal [AE13]) were obtained from Novus Biologicals (NBP2-29926) (Littleton, CO, USA) and 8 Abcam (ab16113) (Cambridge, MA, USA), respectively. This CCHCR1 antibody is generated from 9 rabbits immunized with a KLH conjugated synthetic peptide between 599-627 amino acids from the 10 central region of human CCHCR1. The homology of the 29 peptides between human and mouse is 11 97% (28/29). 12
Deparaffinized skin sections were boiled in 10 mM of citrate buffer (pH 5.0) for antigen 13
unmasking. Sections were incubated in Blocking One Histo (Nacarai tesque, Kyoto, Japan) for 30 14 minutes at room temperature, then incubated with primary antibodies [anti-CCHCR1 (1:100), anti-15 hair cortex Cytokeratin (1:200)] in PBS containing 5% Blocking One Histo and 0.05% Triton-X 100 16 overnight at 4˚C. Sections were then washed and incubated with secondary antibodies [anti-mouse 17
IgG-Alexa488 (1:500), anti-rabbit IgG-Alexa594 (1:500)] for 2 hours at room temperature. Controls 18 for all immunostaining were simultaneously performed by omitting the primary antibody. Sections 19 were cover-slipped using Vectashield with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI) 20 (Vector Laboratories, Burlingame, CA, USA) for nuclei counterstaining and analyzed with Keyence 21 BZ X-700 (Keyence, Tokyo, Japan). 22
23

Morphology of hair shafts 24
Hairs were plucked from mice and analyzed by SEM using a JSM 6510LV (Jeol Co., Tokyo, 25 Japan). between AA and wild-type skin. Figure S11 Filtering scheme used for microarray analysis. Figure  10 S12 Analysis of expression in mouse skin using quantitative PCR and a comparative CT method. 11
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